Tomonari Watabiki

Tomonari Watabiki has extensive work experience in the pharmaceutical industry. Tomonari is currently the Director and Head of RTO Portfolio Strategy at Astellas Gene Therapies since October 2023. Prior to this role, they held the position of Associate Director of Program Management in Research & Technical Operations (RTO) at Astellas Gene Therapies from April 2022 to October 2023.

Before joining Astellas Gene Therapies, Tomonari worked at Astellas Pharma as a Senior Manager in Research Program Management for Drug Discovery Research from January 2016 to April 2022. Tomonari also worked at Astellas Europe as a Manager in Translational Research in EU for Drug Discovery Research from February 2013 to December 2015.

Tomonari's earlier experience includes working at Astellas Pharma as an Asc Manager in Pharmacology Research Labs for Drug Discovery Research from April 2005 to January 2013, and at Yamanochi Pharmaceutical as a Research Scientist in Pharmacology Research Labs from April 2002 to March 2005.

Tomonari Watabiki's education history begins in 1996 when they enrolled in The University of Tokyo to pursue a Bachelor's degree. Tomonari completed their undergraduate studies in the field that has not been specified. Following this, from 2000 to 2002, Tomonari pursued a Master's degree in Pharmacy at the same institution. Finally, in 2011, they obtained their Doctor of Pharmacy (PharmD) degree from The University of Tokyo.

In addition to their academic achievements, Tomonari Watabiki holds a certification as a Pharmacist from the Ministry of Health, Labor and Welfare in Japan. The exact month and year of obtaining this certification have not been provided.